Trump mentions a “very rich, very neurotic” Ozempic user: Elon, is that you?

During a recent White House signing ceremony, President Donald Trump shared an anecdote about a wealthy, well-known businessman friend who uses a weight-loss drug he referred to as a "fat shot." Trump mentioned that this friend was surprised by the drastic price difference for the medication, noting he paid only $88 for it in London compared to $1,300 in New York, PageSix reported. This story was used to highlight the extreme disparity in drug prices between the U.S. and Europe.

Trump's remarks sparked widespread speculation on social media about the identity of the businessman. Many users guessed it was Elon Musk, who has previously acknowledged using weight-loss drugs . However, there's no evidence Musk complained about the drug's price, adding uncertainty.

But, yes Elon Musk has always been open about using Ozempic

Back in late 2022, Musk replied to a fan on Twitter asking how he was looking so trim. His answer? “Fasting” and “Wegovy.” Now here’s the catch—Wegovy and Ozempic are basically siblings. Both are made by Novo Nordisk , and both contain the same active ingredient, semaglutide. The difference? Ozempic is officially for type 2 diabetes, while Wegovy is FDA-approved for weight loss. But they work in pretty much the same way.

These drugs mimic a hormone in the body called GLP-1, which helps regulate blood sugar and makes you feel full. Translation: you eat less, stay full longer, and probably drop some serious weight. That’s why so many celebs, influencers, and even some tech moguls are reportedly jumping on the Ozempic bandwagon.

Now, Musk’s weight loss isn’t just a casual observation. People really noticed. He was looking leaner, sharper, and more energetic, and naturally, fans were curious.

Trump on Ozempic: “A friend of mine who is a businessman… Most of you would've heard of him. Highly neurotic. Brilliant businessman. Seriously overweight. And he takes the fat shot drug... I said it’s not working.”

No freaking way. 😭pic.twitter.com/d06YoLShNH

— johnny maga (@_johnnymaga) May 12, 2025

But here’s where things get a little spicy. Recently, Donald Trump joked at a public event about a “very rich, very neurotic business friend” who’s using what he called a “fat shot” and complained about paying $1,300 in New York when the same thing cost just $88 in London. While Trump didn’t name names, the internet did what it does best—speculate. Elon’s name popped up fast, and though there’s no confirmation that Trump was referring to him, the timing made it juicy enough for people to connect the dots.

So, is Musk the poster child for Ozempic now?
Not officially. But there’s no denying his public admission helped bring the drug into the spotlight even more. What used to be a quiet, doctor-prescribed treatment for diabetes is now headlining in Hollywood, Silicon Valley, and everywhere in between.

Of course, it’s not all smooth sailing. Experts have raised concerns about people using these drugs without medical need, especially for cosmetic reasons. Side effects like nausea, stomach issues, and even more serious complications are very real. Plus, there's the whole supply issue—people with diabetes sometimes struggle to get their prescriptions because it's being scooped up by folks chasing a slimmer figure.

Beyond the personal anecdote, Trump's comments are being interpreted as a strategic lead-up to his administration's push for drug pricing reform . His "most-favored nation" policy aims to align U.S. drug prices with those in the lowest-cost developed nations, potentially addressing wide disparities in medication costs. Although not detailing explicit price caps, Trump’s executive order directs the Department of Health and Human Services to develop appropriate pricing rules.